6505NCM152334: FAMOTIDINE INJECTION.
The FAMOTIDINE INJECTION is a the manufacturer industrial component. Key specifications include administration: INTRAVENOUS, primary_container_type: VIAL, MULTIPLE DOSE, protective_storage_feature: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS, total_primary_container_quantity: 10, primary_container_content_quantity: 20.0 MILLILITERS, active_medicament_medicinal_strength: 200.0 MILLIGRAMS FAMOTIDINE ACTIVE INGREDIENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-646-7199, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAVENOUS |
| primary_container_type | VIAL, MULTIPLE DOSE |
| protective_storage_feature | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| total_primary_container_quantity | 10 |
| primary_container_content_quantity | 20.0 MILLILITERS |
| active_medicament_medicinal_strength | 200.0 MILLIGRAMS FAMOTIDINE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | FAMOTIDINE 10MG/ML INJECTION, 20ML MULTIDOSE VIAL, 10 VIALS/PG |
| NSN | 6505-01-646-7199 |
| ADMINISTRATION | INTRAVENOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 20.0 MILLILITERS |
| PRIMARY CONTAINER TYPE | VIAL, MULTIPLE DOSE |
| SPECIAL FEATURES | FAMOTIDINE INJ; 10MG/ML MULTIPLE DOSE VIAL; 20ML VIALS X 10 VIALS PER TRAY; FAMOTIDINE IS A COMPETITIVE INHIBITOR OF HISTAMINE H2 RECEPTORS; THE PRIMARY CLINICALLY IMPORTANT PHARMACOLOGIC ACTIVITY OF FAMOTIDINE IS INHIBITION OF GASTRIC SECRETION; STORE CONTAINER AT 2-8 DEGREES C; FOR INTRAVENOUS USE ONLY AFTER DILUTION; DILUTED FAMOTIDINE INJECTION SHOULD BE REFRIGERATED AND USED WITHIN 48 HOURS |
| PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | FAMOTIDINE 10MG/ML INJECTION, 20ML MULTIDOSE VIAL, 10 VIALS/PG |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 200.0 MILLIGRAMS FAMOTIDINE ACTIVE INGREDIENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 10 |